Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Helio Liver Test Case-Controlled Performance Study in China (HEPATIC)

NCT05053412 is registered in ClinicalTrials.gov with Helio Genomics as lead sponsor.

NCT NCT05053412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05053412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Helio Liver Test Case-Controlled Performance Study in China (HEPATIC)
Lead sponsor
Helio Genomics
Phase
Observational
Overall status
Completed
Start date
September 1, 2021
Completion date
May 31, 2024
Enrollment
1,556 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma and liver disease